LISINOPRIL

Product NDC: 51655-408
11-digit product format: 516550408
Labeler code: 51655
Product ID: 51655-408_704ea6a9-118f-497c-b9dc-435ce1142f90
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: LISINOPRIL
Dosage form: TABLET
Route: ORAL
Labeler: Northwind Pharmaceuticals, LLC
Application: ANDA075994
Marketing category: ANDA
Marketing start: 2014-11-21
Marketing end: 0000-00-00
Substance: LISINOPRIL
Active strength: 20 mg/1
Pharmacologic classes: Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
51655-408-52	2026-01-07	C162847	48780-1	9d75b9d0-926e-f424-e053-dadaa90a57ce	6d78a1a2-f076-4cfd-a1a2-1049db43cf1e
51655-408-52	2020-01-31	C162847	48780-1	9d75b9d0-926e-f424-e053-dadaa90a57ce	6d78a1a2-f076-4cfd-a1a2-1049db43cf1e

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version	Uploaded
LISINOPRIL	ACTIVE INGREDIENT	E7199S1YWR	LISINOPRIL TABLET [NORTHWIND PHARMACEUTICALS, LLC]	1
LISINOPRIL ANHYDROUS	ACTIVE MOIETY	7Q3P4BS2FD	LISINOPRIL TABLET [NORTHWIND PHARMACEUTICALS, LLC]	1

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51655-408	LISINOPRIL TABLET [NORTHWIND PHARMACEUTICALS, LLC]	1	Legacy NDC	20141218_6d78a1a2-f076-4cfd-a1a2-1049db43cf1e.zip